Advances in solid dosage form manufacturing technology.
Currently, the pharmaceutical and healthcare industries are moving through a period of unparalleled change. Major multinational pharmaceutical companies are restructuring, consolidating, merging and more importantly critically assessing their competitiveness to ensure constant growth in an ever-more demanding market where the cost of developing novel products is continuously increasing. The pharmaceutical manufacturing processes currently in existence for the production of solid oral dosage forms are associated with significant disadvantages and in many instances provide many processing problems. Therefore, it is well accepted that there is an increasing need for alternative processes to dramatically improve powder processing, and more importantly to ensure that acceptable, reproducible solid dosage forms can be manufactured. Consequently, pharmaceutical companies are beginning to invest in innovative processes capable of producing solid dosage forms that better meet the needs of the patient while providing efficient manufacturing operations. This article discusses two emerging solid dosage form manufacturing technologies, namely hot-melt extrusion and fluidized hot-melt granulation.
Andrews
Gavin P
GP
School of Pharmacy, Queen's University Belfast, Belfast BT9 7BL, Northern Ireland, UK. g.andrews@qub.ac.uk
D002626:Chemistry, Pharmaceutical / Q000639:trends*; D004337:Drug Carriers / Q000737:chemistry*; D016503:Drug Delivery Systems / Q000639:trends*; D004345:Drug Industry / Q000639:trends*; D005544:Forecasting; D013678:Technology, Pharmaceutical / Q000639:trends*
D004337:Drug Carriers